After his recent pasting over the abysmal state of SA’s hospitals, health minister Aaron Motsoaledi can take comfort from the praise his department has received for becoming the world’s first to adopt a new, far better drug‚ bedaquiline, to combat multidrug-resistant tuberculosis. Doctors Without Borders applauded this "bold step aimed at scaling up access to an effective new drug‚ making MDR-TB treatment more tolerable and reducing the devastating impact of side effects caused by the injectable agents".

In March, Basil Read’s newish CEO Khathutshelo Mapasa assured investors that the construction giant — which, like its peers, scored big from 2010 World Cup projects — remained viable despite having debts almost twice its assets. But as the 2018 World Cup kicked off in Russia, the firm filed for business rescue after a consortium of lenders declined to stump up the money to carry it through the hard times afflicting the sector. The firm’s share price dropped almost 89%, having ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now